• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有西地那非的固体脂质纳米粒的体外与离体毒理学试验。

In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles.

机构信息

Institut für Pharmazeutische Technologie, TU Braunschweig, Braunschweig, Germany.

出版信息

Inhal Toxicol. 2013 Aug;25(9):536-43. doi: 10.3109/08958378.2013.810315.

DOI:10.3109/08958378.2013.810315
PMID:23905970
Abstract

The aim of this study was to investigate the potential cytotoxicity of solid lipid nanoparticles (SLN) loaded with sildenafil. The SLNs were tested as a new drug delivery system (DDS) for the inhalable treatment of pulmonary hypertension in human lungs. Solubility of sildenafil in SLN lipid matrix (30:70 phospholipid:triglyceride) was determined to 1% sildenafil base and 0.1% sildenafil citrate, respectively. Sildenafil-loaded SLN with particle size of approximately 180 nm and monomodal particle size distribution were successfully manufactured using a novel microchannel homogenization method and were stable up to three months. Sildenafil-loaded SLN were then used in in vitro and ex vivo models representing lung and heart tissue. For in vitro models, human alveolar epithelial cell line (A459) and mouse heart endothelium cell line (MHEC5-T) were used. For ex vivo models, rat precision cut lung slices (PCLS) and rat heart slices (PCHS) were used. All the models were treated with plain SLN and sildenafil-loaded SLN in a concentration range of 0-5000 µg/ml of lipid matrix. The toxicity was evaluated in vitro and ex vivo by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Median lethal dose 50% (LD50) values for A549 cells and PCLS were found to be in the range of 1200-1900 µg/ml while for MHEC5-T cells and precision cut heart slices values were found between 1500 and 2800 µg/ml. PCHS showed slightly higher LD50 values in comparison to PCLS. Considering the toxicological aspects, sildenafil-loaded SLN could have potential in the treatment of pulmonary hypertension via inhalation route.

摘要

本研究旨在探究载有西地那非的固体脂质纳米粒(SLN)的潜在细胞毒性。这些 SLN 被测试为一种新的药物传递系统(DDS),用于治疗人类肺部的肺动脉高压。测定了西地那非在 SLN 脂质基质(30:70 磷脂:甘油三酯)中的溶解度,分别为 1%西地那非碱和 0.1%西地那非柠檬酸盐。采用新型微通道匀化法成功制备了粒径约为 180nm、单模态粒径分布的载有西地那非的 SLN,且在 3 个月内保持稳定。随后,将载有西地那非的 SLN 用于代表肺和心脏组织的体外和离体模型。体外模型采用人肺泡上皮细胞系(A459)和小鼠心脏内皮细胞系(MHEC5-T)。离体模型采用大鼠精密切割肺切片(PCLS)和大鼠心脏切片(PCHS)。所有模型均以脂质基质浓度为 0-5000μg/ml 的普通 SLN 和载有西地那非的 SLN 进行处理。通过 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)测定法在体外和离体模型中评价毒性。A549 细胞和 PCLS 的半数致死剂量 50%(LD50)值为 1200-1900μg/ml,而 MHEC5-T 细胞和精密切割心脏切片的 LD50 值在 1500-2800μg/ml 之间。与 PCLS 相比,PCHS 的 LD50 值略高。考虑到毒理学方面,载有西地那非的 SLN 有可能通过吸入途径治疗肺动脉高压。

相似文献

1
In vitro and ex vivo toxicological testing of sildenafil-loaded solid lipid nanoparticles.载有西地那非的固体脂质纳米粒的体外与离体毒理学试验。
Inhal Toxicol. 2013 Aug;25(9):536-43. doi: 10.3109/08958378.2013.810315.
2
Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application.载有西地那非的固体脂质纳米粒分散体(SLN)的理化特性及其在肺部的应用。
Int J Pharm. 2014 Dec 10;476(1-2):41-9. doi: 10.1016/j.ijpharm.2014.09.031. Epub 2014 Sep 26.
3
Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models.固体脂质纳米粒在体外和离体肺模型中的低细胞毒性。
Inhal Toxicol. 2009 Jul;21 Suppl 1:104-9. doi: 10.1080/08958370903005769.
4
Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction.枸橼酸西地那非固体脂质纳米粒口服制剂:一种新型制剂,具有更高的生物利用度和更持久的作用,用于治疗勃起功能障碍。
Expert Opin Drug Deliv. 2014 Jul;11(7):1015-22. doi: 10.1517/17425247.2014.912212. Epub 2014 Apr 19.
5
Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor.用于通过靶向递送磷酸二酯酶-5抑制剂潜在治疗肺动脉高压的雾化固体脂质纳米粒。
Int J Pharm. 2017 Jan 30;517(1-2):312-321. doi: 10.1016/j.ijpharm.2016.12.026. Epub 2016 Dec 12.
6
Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.可生物降解的载有西地那非纳米粒经 Aeroneb Pro 雾化的性能:制剂方面和纳米粒对雾化的稳定性。
Int J Pharm. 2012 Jan 17;422(1-2):398-408. doi: 10.1016/j.ijpharm.2011.10.012. Epub 2011 Oct 6.
7
Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters.可生物降解纳米颗粒平台用于西地那非的开发:通过因子设计分析结合应用电荷修饰支化聚酯进行制剂优化。
J Control Release. 2012 Feb 10;157(3):469-77. doi: 10.1016/j.jconrel.2011.09.058. Epub 2011 Sep 10.
8
Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.用于减少B16F10黑色素瘤在肺部定植的依托泊苷负载型固体脂质纳米粒
Biomed Pharmacother. 2014 Mar;68(2):231-40. doi: 10.1016/j.biopha.2014.01.004. Epub 2014 Jan 25.
9
A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung.吸入式固体脂质纳米粒作为肺部潜在药物传递系统的毒理学评价
Eur J Pharm Biopharm. 2010 Jun;75(2):107-16. doi: 10.1016/j.ejpb.2010.02.014. Epub 2010 Mar 3.
10
Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.载利培酮固体脂质纳米粒的长期稳定性、生物相容性和口服递药潜能。
Int J Pharm. 2012 Oct 15;436(1-2):798-805. doi: 10.1016/j.ijpharm.2012.07.058. Epub 2012 Aug 4.

引用本文的文献

1
Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models.使用体外和离体模型评估药物渗透增强作用
Pharmaceuticals (Basel). 2025 Jan 31;18(2):195. doi: 10.3390/ph18020195.
2
Excipients for Novel Inhaled Dosage Forms: An Overview.新型吸入制剂辅料:概述。
AAPS PharmSciTech. 2024 Feb 14;25(2):36. doi: 10.1208/s12249-024-02741-w.
3
Recent Options and Techniques to Assess Improved Bioavailability: In Vitro and Ex Vivo Methods.评估生物利用度改善的最新方法和技术:体外和离体方法
Pharmaceutics. 2023 Apr 4;15(4):1146. doi: 10.3390/pharmaceutics15041146.
4
Pulmonary drug delivery for acute respiratory distress syndrome.肺部给药治疗急性呼吸窘迫综合征。
Pulm Pharmacol Ther. 2023 Apr;79:102196. doi: 10.1016/j.pupt.2023.102196. Epub 2023 Jan 20.
5
Functional changes in long-term incubated rat precision-cut lung slices.长期孵育的大鼠离体肺切片的功能变化。
Respir Res. 2022 Sep 20;23(1):261. doi: 10.1186/s12931-022-02169-5.
6
Pharmacological Strategies and Recent Advancement in Nano-Drug Delivery for Targeting Asthma.用于靶向治疗哮喘的纳米药物递送的药理学策略及最新进展
Life (Basel). 2022 Apr 18;12(4):596. doi: 10.3390/life12040596.
7
Modifying and Integrating and Respiratory Models for Inhalation Drug Screening.用于吸入药物筛选的模型修改、整合及呼吸模型
Front Bioeng Biotechnol. 2020 Oct 23;8:581995. doi: 10.3389/fbioe.2020.581995. eCollection 2020.
8
Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles.含载他达拉非聚乳酸-羟基乙酸共聚物纳米粒的干粉吸入器的研制。
Res Pharm Sci. 2017 Jun;12(3):222-232. doi: 10.4103/1735-5362.207203.
9
Evaluation of inflammatory and immune responses in long-term cultured human precision-cut lung slices.长期培养的人精密切割肺切片中炎症和免疫反应的评估
Hum Vaccin Immunother. 2017 Feb;13(2):351-358. doi: 10.1080/21645515.2017.1264794.
10
Metabolic Functions of the Lung, Disorders and Associated Pathologies.肺的代谢功能、疾病及相关病理状况
J Clin Med Res. 2016 Oct;8(10):689-700. doi: 10.14740/jocmr2668w. Epub 2016 Aug 30.